Addiction Medicine Journal Club: Do Urine Drug Tests Reveal Substance Misuse? - Audio Episode 4

INSTRUCTIONS - Start Here

Addiction is a disease that can be treated, and this audio will help you stay up to date with the latest research that you can use in your addiction medicine practice. In this episode of Addiction Medicine Journal Club we discuss "Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?".

Citation: Larochelle,M.R., Cruz, R., Kosakowski, S. et al.  Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? J GEN INTERN MED (2021).  https://doi.org/10.1007/s11606-021-07095-8.

Available at https://link.springer.com/article/10.1007/s11606-021-07095-8#citeas

In our introduction we discuss a new FDA warning regarding dental problems with sublingual buprenorphine, and the prevalence of dental problems in our patients. We also discuss reducing daily alcohol consumption during Dry January. If you are looking for some resources for your patients on controlling problematic drinking, take a look at Moderation Management and Rethinking Drinking.

If you want your comments about this article included in a future episode, leave them in your CME quiz, email us at [email protected], talk to us on Twitter @AddicionMedJC, or even record a comment using the voice memo app on your phone and email it to us. Thank you for being part of the conversation.

Credits
Host: Sonya Del Tredici, MD
Host: John Keenan, MD
Music: Benjamin Kennedy
Audio Production: Angela Ohlfest
CME Coordinator: georgeanna ledgerwood, MLIS/LMT
Sponsor: WellSpan Health

1. Discuss the study design, results, and limitations of the research reviewed and how to apply those results to current practice.
2. Analyze how the conclusions of the featured article affect their current treatment using opioid medications.
3. Discuss the featured article & its impact on patient outcomes.

AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours), Act 13 Patient Safety/Risk Management Credits (0.50 hours), Act 124 Opioid Continuing Education Qualified (0.50 hours)

Friday, April 1, 2022, 6:30 AM - Sunday, December 31, 2023, 7:00 AM

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.